Suppr超能文献

健康体检估算肾小球滤过率的年度变化与终末期肾病相关。

Annual variation of estimated glomerular filtration rate in health check-ups associated with end-stage kidney disease.

机构信息

Department of Diabetes and Endocrinology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Department of Public Health, Health Management, and Policy, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.

出版信息

Sci Rep. 2024 Sep 10;14(1):21065. doi: 10.1038/s41598-024-72353-8.

Abstract

Estimated glomerular filtration rate (eGFR) variation is associated with end-stage kidney disease (ESKD) development in patients with chronic kidney disease; whether annual variations in eGFR at health check-ups is associated with ESKD risk in the general population is unclear. We conducted a retrospective cohort study using Japanese national medical insurance claims from 2013 to 2020. Individuals who had their eGFR levels measured three times in annual health check-ups were included (N = 115,191), and the coefficient of variation of eGFR (CVeGFR) was calculated from 3-point eGFR. The end-point was ESKD as reported in the claims data. We analyzed the association between CVeGFR and ESKD incidence after adjusting for conventional ESKD risk factors. The CVeGFR median distribution was 5.7% (interquartile range: 3.5-8.5%). During a median follow-up period of 3.74 years, 164 patients progressed to ESKD. ESKD incidence was significantly higher in the highest quartile group (CVeGFR ≥ 8.5%) than in the other groups (P < 0.0001). After adjusting for risk factors, individuals with CVeGFR ≥ 8.5% had a significantly high ESKD incidence (adjusted hazard ratio: 3.01; 95% CI 2.14-4.30). High CVeGFR in annual health check-ups was associated with high ESKD incidence, independent of its other conventional risk factors, in the general population.

摘要

估算肾小球滤过率 (eGFR) 的变化与慢性肾脏病患者的终末期肾病 (ESKD) 发展有关;在普通人群中,健康检查时 eGFR 的年度变化是否与 ESKD 风险相关尚不清楚。我们使用 2013 年至 2020 年的日本国家医疗保险理赔数据进行了回顾性队列研究。纳入了在年度健康检查中 eGFR 水平测量三次的个体(N=115191),并从 3 点 eGFR 计算 eGFR 的变异系数 (CVeGFR)。终点是理赔数据中报告的 ESKD。我们在调整了传统的 ESKD 风险因素后,分析了 CVeGFR 与 ESKD 发病率之间的关系。CVeGFR 的中位数分布为 5.7%(四分位间距:3.5-8.5%)。在 3.74 年的中位随访期间,有 164 名患者进展为 ESKD。最高四分位组(CVeGFR≥8.5%)的 ESKD 发病率明显高于其他组(P<0.0001)。在校正风险因素后,CVeGFR≥8.5%的个体 ESKD 发病率显著升高(校正后的危险比:3.01;95%CI 2.14-4.30)。在普通人群中,年度健康检查中 CVeGFR 较高与 ESKD 发病率较高相关,独立于其其他传统风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c63/11387403/4e11e7c55bca/41598_2024_72353_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验